Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

2 results

  • Active substance : fer
  • Topics : Diseases and conditions
  • Topics : Liver diseases
  • Topics : Congenital, genetic and rare diseases
Filter
Topic
  • Diseases and conditions (2)
  • Plus ...
    • Congenital, genetic and rare diseases (2)
    • Digestive system diseases (2)
    • Plus ...
      • Liver diseases (2)
    • Endocrine system and metabolic diseases (2)
    • Plus ...
      • Metabolic diseases (2)
  • Economics and public health (1)
  • Plus ...
    • Health economics (1)
    • Screening, prevention (1)
Content type
  • Practice Guidelines and Other Guides (2)
  • Plus ...
    • Practice guidelines (1)
    • Public Health guideline (1)
Manufacturer
  • industriels (1)
Language
  • Français (2)
Active substance
  • alanine (2)
  • alcool (2)
  • aluminium (1)
  • chlorure de sodium (1)
  • fer (2)
  • fer ferreux (1)
  • fer ferrique (1)
  • zinc (1)
 More filter Other Filter Icon
Search Export

Practice guidelines and other guides - 2 results

  • Clinical and economic assessment of screening for HFE1 haemochromatosis in 2004

    Public Health guideline - Posted on 1/4/2004 - Mis à jour le 12/12/2006
    Download abstract
    Add to my selection

  • Management of patients with HFE-related haemochromatosis (Type 1 haemochromatosis)

    Practice guidelines - Posted on 1/7/2005 - Mis à jour le 26/9/2006
    Download abstract
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
2vmSsQY9DEFzgw8x